Scotia Capital »

Outlook Therapeutics shares owned by Scotia Capital

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Scotia Capital from 13F filings

Historical chart of Scotia Capital investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Scotia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Scotia Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $112k 284k 0.39
2023-09-30 $75k 338k 0.22
2023-06-30 $113k 65k 1.74